Stock listing
TWSE:6918 A Plus Biotechnology Co Ltd (愛派司) 股價
Follow A Plus Biotechnology Co Ltd into a list and get an email when it puts out news.
Share price · TWSE:6918
$70.70 TWD -2.50 (-3.4%)
Close on Nov 20, 2026
- Day range
- $68.60 – $71.00 TWDNov 20, 2026
- Volume
- 111,199 sharesNov 20, 2026
- Market cap
- $2.41B TWDAt the close on Nov 20, 2026 · price × 34.07M shares outstanding
- 52-week range
- $68.30 – $90.50 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $2.72M TWDMedian day 25,001 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:6918 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $70.70 | -2.50 | -3.4% | $70.80 | $71.00 | $68.60 | 111,199 | |
| $73.20 | +0.20 | +0.3% | $72.50 | $73.20 | $71.60 | 45,839 | |
| $73.00 | -0.80 | -1.1% | $74.40 | $74.40 | $72.60 | 15,665 | |
| $73.80 | -0.40 | -0.5% | $73.00 | $73.80 | $73.00 | 22,893 | |
| $74.20 | 0.00 | 0.0% | $74.20 | $74.20 | $74.00 | 12,015 | |
| $74.20 | -0.70 | -0.9% | $75.00 | $75.00 | $73.80 | 12,007 | |
| $74.90 | +0.20 | +0.3% | $73.50 | $74.90 | $73.50 | 33,040 | |
| $74.70 | +0.50 | +0.7% | $72.60 | $74.90 | $72.60 | 52,047 | |
| $74.20 | +2.30 | +3.2% | $75.00 | $75.00 | $72.70 | 31,061 | |
| $71.90 | -0.40 | -0.6% | $71.20 | $71.90 | $70.60 | 50,077 | |
| $72.30 | -1.20 | -1.6% | $73.00 | $73.00 | $72.30 | 15,495 | |
| $73.50 | +0.80 | +1.1% | $72.70 | $73.70 | $72.60 | 70,141 | |
| $72.70 | -0.50 | -0.7% | $73.30 | $73.50 | $72.60 | 47,721 | |
| $73.20 | +0.20 | +0.3% | $73.20 | $73.20 | $72.80 | 21,124 | |
| $73.00 | -1.10 | -1.5% | $74.00 | $74.00 | $73.00 | 35,035 | |
| $74.10 | -0.50 | -0.7% | $73.90 | $74.10 | $73.50 | 8,004 | |
| $74.60 | +0.40 | +0.5% | $75.00 | $75.00 | $74.20 | 9,600 | |
| $74.20 | +0.70 | +1.0% | $76.00 | $76.00 | $73.60 | 35,236 | |
| $73.50 | 0.00 | 0.0% | $73.50 | $73.50 | $73.50 | 0 | |
| $73.50 | -0.50 | -0.7% | $75.00 | $75.20 | $73.50 | 51,000 | |
| $74.00 | -0.60 | -0.8% | $75.10 | $75.20 | $74.00 | 34,300 | |
| $74.60 | 0.00 | 0.0% | $74.30 | $75.20 | $74.30 | 26,000 | |
| $74.60 | -0.40 | -0.5% | $75.00 | $75.20 | $74.60 | 10,820 | |
| $75.00 | +0.20 | +0.3% | $74.00 | $75.80 | $74.00 | 22,000 | |
| $74.80 | -1.00 | -1.3% | $73.60 | $75.10 | $73.60 | 18,000 | |
| $75.80 | +0.80 | +1.1% | $75.00 | $76.20 | $75.00 | 35,000 | |
| $75.00 | -0.90 | -1.2% | $75.60 | $75.60 | $74.20 | 19,017 | |
| $75.90 | +0.40 | +0.5% | $75.00 | $75.90 | $75.00 | 39,000 | |
| $75.50 | +1.80 | +2.4% | $73.60 | $76.90 | $73.60 | 119,002 | |
| $73.70 | -0.30 | -0.4% | $74.50 | $74.60 | $73.70 | 233,000 | |
| $74.00 | +0.20 | +0.3% | $73.50 | $74.00 | $73.50 | 93,000 | |
| $73.80 | +0.20 | +0.3% | $74.00 | $74.00 | $73.60 | 26,000 | |
| $73.60 | -0.30 | -0.4% | $73.40 | $73.60 | $73.10 | 21,000 | |
| $73.90 | -0.40 | -0.5% | $74.30 | $74.90 | $73.90 | 31,000 | |
| $74.30 | +0.30 | +0.4% | $74.00 | $74.40 | $73.50 | 12,000 | |
| $74.00 | -0.20 | -0.3% | $74.10 | $74.10 | $73.50 | 17,000 | |
| $74.20 | -0.90 | -1.2% | $74.00 | $74.30 | $74.00 | 16,010 | |
| $75.10 | +0.30 | +0.4% | $74.50 | $75.40 | $74.50 | 24,000 | |
| $74.80 | -0.20 | -0.3% | $75.50 | $75.80 | $74.50 | 5,000 | |
| $75.00 | -0.20 | -0.3% | $75.00 | $75.00 | $75.00 | 2,000 | |
| $75.20 | +0.30 | +0.4% | $75.00 | $75.30 | $75.00 | 4,000 | |
| $74.90 | +0.90 | +1.2% | $75.00 | $77.00 | $74.00 | 25,000 | |
| $74.00 | +0.50 | +0.7% | $73.50 | $74.40 | $73.50 | 9,012 | |
| $73.50 | +0.40 | +0.5% | $73.50 | $73.50 | $73.50 | 3,200 | |
| $73.10 | +0.20 | +0.3% | $72.60 | $74.10 | $72.60 | 36,000 | |
| $72.90 | -1.80 | -2.4% | $74.00 | $74.00 | $72.90 | 64,100 | |
| $74.70 | -2.70 | -3.5% | $75.50 | $75.80 | $73.40 | 111,000 | |
| $77.40 | -0.10 | -0.1% | $77.80 | $77.80 | $77.00 | 22,000 | |
| $77.50 | -0.50 | -0.6% | $77.70 | $77.70 | $76.90 | 35,000 | |
| $78.00 | +0.20 | +0.3% | $77.70 | $78.00 | $77.00 | 18,016 | |
| $77.80 | +0.70 | +0.9% | $77.90 | $80.00 | $76.80 | 51,000 | |
| $77.10 | +0.90 | +1.2% | $78.40 | $78.40 | $77.10 | 18,000 | |
| $76.20 | -1.40 | -1.8% | $75.80 | $77.00 | $75.80 | 20,000 | |
| $77.60 | +0.40 | +0.5% | $77.50 | $77.80 | $77.00 | 31,004 | |
| $77.20 | -0.80 | -1.0% | $77.00 | $77.50 | $76.90 | 25,002 | |
| $78.00 | 0.00 | 0.0% | $79.00 | $79.00 | $76.90 | 31,000 | |
| $78.00 | +3.50 | +4.7% | $75.00 | $80.80 | $75.00 | 104,005 | |
| $74.50 | +0.50 | +0.7% | $74.60 | $75.00 | $74.00 | 25,000 | |
| $74.00 | -0.50 | -0.7% | $74.20 | $74.20 | $73.10 | 37,013 | |
| $74.50 | +0.10 | +0.1% | $74.50 | $74.80 | $74.00 | 19,000 | |
| $74.40 | +0.40 | +0.5% | $75.90 | $75.90 | $74.30 | 77,000 | |
| $74.00 | 0.00 | 0.0% | $74.00 | $74.30 | $74.00 | 18,000 |
- Ticker
- TWSE:6918
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- TWSE
- Currency
- TWD
A Plus Biotechnology Co Ltd on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
Valuation
P/E 13.0× against a median of 14.7×: 3rd lowest of 8 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $2.08B TWD
- P/E
- 13.0×
- EV/sales
- 2.4×
- EV/EBITDA
- 8.6×
- Price/book
- 2.0×
- Gross margin
- 66.8%
- Operating margin
- 24.0%
- Net margin
- 20.9%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| A Plus Biotechnology Co Ltd · TWSE:6918 | US$73.07M | US$63.19M | 13.0× | 2.4× | 8.6× | 2.0× | 20.9% | 0.1× | n/a |
| Zomedica Corp. · OTC:ZOMDF | US$78.49M | US$71.21M | n/a | 1.8× | n/a | 0.8× | −41.3% | 0.0× | 0.10 |
| SkinHealth Systems Inc. · NASDAQ:SKIN | US$77.00M | US$228.9M | n/a | 0.8× | 8.0× | 1.4× | −6.3% | 4.7× | 1.24 |
| Graphy Inc. · KRX:318060 | US$76.80M | US$76.08M | n/a | 4.4× | n/a | 6.8× | −48.1% | 0.0× | n/a |
| L&K BIOMED Co., Ltd. · KRX:156100 | US$76.55M | US$61.13M | 37.3× | 2.1× | 24.3× | 1.6× | 6.9% | 0.0× | n/a |
| Wellell Inc. · TWSE:4106 | US$73.78M | US$52.11M | 13.1× | 0.7× | 5.4× | 1.0× | 7.4% | 0.1× | n/a |
| C-Rad AB Class B · OMXSTO:CRAD_B | US$72.97M | US$59.62M | 15.7× | 1.5× | 9.1× | 2.0× | 11.4% | 0.0× | n/a |
| CG MedTech Co.Ltd. · KRX:056090 | US$71.34M | US$72.81M | 14.7× | 1.9× | 20.1× | 1.0× | 12.8% | 0.1× | n/a |
| Covalon Technologies Ltd. · TSXV:COV | US$71.26M | US$57.74M | 23.3× | 2.4× | 16.8× | 3.2× | 12.8% | 0.0× | 0.60 |
| Sewoonmedical Co., Ltd. · KRX:100700 | US$70.11M | −US$3.91M | 6.8× | −0.1× | −0.3× | 0.6× | 20.9% | 0.0× | n/a |
| MITECH Co., Ltd. · KRX:179290 | US$69.97M | US$21.09M | 4.6× | 0.4× | 1.2× | 0.7× | 30.3% | 0.0× | n/a |
| Median of the others | US$73.37M | US$60.38M | 14.7× | 1.6× | 8.6× | 1.2× | 9.4% | 0.0× | 0.60 |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 835.9M | 769.6M | 675.0M | 615.5M | 541.9M |
| Cost of revenue | 262.4M | 234.8M | 214.4M | 243.9M | 195.5M |
| Gross profit | 573.5M | 534.8M | 460.7M | 371.5M | 346.4M |
| Research and development | 46.6M | 53.3M | 59.5M | 77.0M | 63.1M |
| Selling, general and administrative | 318.1M | 299.2M | 233.4M | 227.9M | 237.2M |
| Operating income | 208.8M | 182.3M | 167.7M | 66.6M | 46.1M |
| Depreciation and amortization | 27.2M | 26.7M | 26.4M | 24.9M | 21.4M |
| EBITDA | 236.0M | 209.0M | 194.1M | 91.5M | 67.6M |
| Interest expense | 2.17M | 2.19M | 2.71M | 2.66M | 2.20M |
| Income before tax | 216.1M | 187.6M | 3.04M | 68.1M | 46.1M |
| Net income | 169.4M | 151.1M | -11.3M | 45.7M | 32.9M |
| Earnings per share, basic | 4.96 | 4.96 | -0.37 | 1.50 | 1.08 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 604.4M | 361.0M | 319.1M | 237.7M | 305.1M |
| Short-term investments | 5.00M | 31.0M | 1.00M | 1.00M | 1.00M |
| Receivables | 177.6M | 179.0M | 141.7M | 145.1M | 128.9M |
| Inventory | 354.5M | 286.9M | 283.8M | 295.7M | 300.7M |
| Current assets | 1.19B | 896.8M | 769.6M | 713.6M | 761.3M |
| Total assets | 1.55B | 1.18B | 1.07B | 1.17B | 1.21B |
| Accounts payable | 41.0M | 39.4M | 28.8M | 42.0M | 42.1M |
| Current liabilities | 198.1M | 163.3M | 142.8M | 173.6M | 203.3M |
| Long-term debt | 82.4M | 87.2M | 93.8M | 116.4M | 154.0M |
| Total liabilities | 284.4M | 258.3M | 243.4M | 296.7M | 361.9M |
| Shareholders' equity | 1.26B | 919.0M | 827.9M | 877.8M | 843.9M |
| Shares outstanding | 34.1M | 30.5M | 30.2M | 30.5M | 30.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | 158.9M | 161.0M | 159.1M | 60.6M | 53.0M |
| Capital spending | -13.6M | -9.13M | -9.80M | -36.8M | -224.9M |
| Free cash flow | 145.3M | 151.8M | 149.3M | 23.9M | -172.0M |
| Dividends paid | -121.9M | -81.5M | -21.1M | -15.2M | -14.3M |
| Share buybacks | -38.7M | -16.3M | -14.2M | 0 | |
| Change in cash | 243.4M | 41.9M | 81.4M | -67.4M | 15.8M |
Cap table
Built by 6ix from A Plus Biotechnology Co Ltd’s releases
- Common shares
- 34,071,000
- Fully diluted
- 34,071,000
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 34,071,000 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 34,071,000 |
Log in to ask 6ix AI your own questions about A Plus Biotechnology Co Ltd.